Newsroom

01/01/2020

Many of our clients have contacted us with questions about the Department of Transportation's (DOT) Notice of Proposed Rulemaking (NPRM), CFR Part 40 covering drug testing guidelines for regulated industries (Read Full NPRM). Clinical Reference Laboratory is aware of the NPRM and has thoroughly evaluated the impact of these proposed regulations on the laboratory.

To assist you in the preparation of your specific comments to the DOT, as it also directly impacts your business, we have enclosed a copy of our response to the DOT.

All comments must be submitted back to the DOT no later than March 20, 2010.